These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14734473)

  • 41. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer.
    Fan C; Yu J; Liu Y; Xu H; Wang E
    Pathol Oncol Res; 2012 Jul; 18(3):549-56. PubMed ID: 20853080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
    Swords K; Wallen EM; Pruthi RS
    Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
    Magi-Galluzzi C; Tsusuki T; Elson P; Simmerman K; LaFargue C; Esgueva R; Klein E; Rubin MA; Zhou M
    Prostate; 2011 Apr; 71(5):489-97. PubMed ID: 20878952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.
    Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y
    Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.
    Parray A; Siddique HR; Kuriger JK; Mishra SK; Rhim JS; Nelson HH; Aburatani H; Konety BR; Koochekpour S; Saleem M
    Int J Cancer; 2014 Dec; 135(11):2493-506. PubMed ID: 24752651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rates of clinically significant prostate cancer in African Americans increased significantly following the 2012 US Preventative Services Task Force recommendation against prostate specific antigen screening: A Single Institution Retrospective Study.
    Arace J; Flores V; Monaghan T; Robins D; Karanikolas N; Winer A; Weiss J
    Int J Clin Pract; 2020 Feb; 74(2):e13447. PubMed ID: 31750596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
    Rosen P; Pfister D; Young D; Petrovics G; Chen Y; Cullen J; Böhm D; Perner S; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S
    Urology; 2012 Oct; 80(4):749-53. PubMed ID: 22950997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer.
    Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
    Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
    Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy.
    Lee EW; Marien T; Laze J; Agalliu I; Lepor H
    BJU Int; 2012 Oct; 110(8):1129-33. PubMed ID: 22429893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups.
    Kim TJ; Lee JY; Hwang TK; Kang CS; Choi YJ
    J Surg Oncol; 2011 Oct; 104(5):472-9. PubMed ID: 21656527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
    Wenzel M; Nocera L; Collà Ruvolo C; Würnschimmel C; Tian Z; Shariat SF; Saad F; Briganti A; Tilki D; Graefen M; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
    J Urol; 2021 Jul; 206(1):69-79. PubMed ID: 33683934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Connelly RR; Moul JW
    J Urol; 1998 Aug; 160(2):459-65. PubMed ID: 9679898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
    Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
    Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
    Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
    Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.